Enalaprilat Injection
Product Images NDC 51662-1477

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Enalaprilat (NDC 51662-1477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Enalaprilat injection, USP is not recommended for use during the 2nd and 3rd trimesters of pregnancy as it may result in harm or death to the developing fetus. When pregnancy is detected, this medication should be stopped immediately. More details and warnings can be found in the section labeled "Fetal/Neonatal Morbidity and Mortality."*

FDA Label Image

S3erialized Labeling (Serialized Labeling)

This is a description of a pharmaceutical product. It is Enalaprilat injection, USP, intended for IV use only. The NDC is 0143-9787-01 and the lot number is 1903097.1. The manufacturer's package insert should be consulted before use. The product is distributed by HF Acquisition Co. located in Mukilteo, Washington. The text also includes prescription use indications and dosage information but it is difficult to interpret due to errors in the .*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Viallabeling)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.